SNHG25 and colon adenocarcinoma: Notably, we reveal a possible underlying mechanism whereby the expression level of ZMYND8 may be altered upon binding to specific antitumor drugs, which in turn regulates the availability of miRNAs through the ceRNA mechanism and indirectly downregulates the expression of SNHG25, thereby inhibiting the progression of COAD (Figure S2).